These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1646182)

  • 1. Effect of serotonin re-uptake inhibition by fluoxetine on body weight and spontaneous food choice in obesity.
    Pijl H; Koppeschaar HP; Willekens FL; Op de Kamp I; Veldhuis HD; Meinders AE
    Int J Obes; 1991 Mar; 15(3):237-42. PubMed ID: 1646182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for brain serotonin-mediated control of carbohydrate consumption in normal weight and obese humans.
    Pijl H; Koppeschaar HP; Cohen AF; Iestra JA; Schoemaker HC; Frölich M; Onkenhout W; Meinders AE
    Int J Obes Relat Metab Disord; 1993 Sep; 17(9):513-20. PubMed ID: 8220653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the 5-HT re-uptake inhibitor fluoxetine on food intake and body weight in healthy male subjects.
    McGuirk J; Silverstone T
    Int J Obes; 1990 Apr; 14(4):361-72. PubMed ID: 2361813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotoninergic manipulation, meal-induced satiety and eating pattern: effect of fluoxetine in obese female subjects.
    Lawton CL; Wales JK; Hill AJ; Blundell JE
    Obes Res; 1995 Jul; 3(4):345-56. PubMed ID: 8521151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tianeptine, a specific serotonin uptake enhancer, decreases ethanol intake in rats.
    Daoust M; Compagnon P; Legrand E; Mocaër E
    Alcohol Alcohol; 1992 Jan; 27(1):15-7. PubMed ID: 1580922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of fluoxetine on body weight, body composition and visceral fat accumulation.
    Visser M; Seidell JC; Koppeschaar HP; Smits P
    Int J Obes Relat Metab Disord; 1993 May; 17(5):247-53. PubMed ID: 8389333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ineffectiveness of parenteral fluoxetine or RU-486 to alter long-term food intake, body weight or body composition of genetically obese mice.
    Dubuc PU; Peterson CM
    J Pharmacol Exp Ther; 1990 Dec; 255(3):976-9. PubMed ID: 2124625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine: a randomized clinical trial in the treatment of obesity.
    Goldstein DJ; Rampey AH; Enas GG; Potvin JH; Fludzinski LA; Levine LR
    Int J Obes Relat Metab Disord; 1994 Mar; 18(3):129-35. PubMed ID: 8186809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of fluoxetine, a selective serotonin-uptake inhibitor, in the treatment of obesity: a dose-response study (with a commentary by Michael Weintraub).
    Levine LR; Enas GG; Thompson WL; Byyny RL; Dauer AD; Kirby RW; Kreindler TG; Levy B; Lucas CP; McIlwain HH
    Int J Obes; 1989; 13(5):635-45. PubMed ID: 2583918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.
    Muls E; Kolanowski J; Scheen A; Van Gaal L;
    Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1713-21. PubMed ID: 11753595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexfenfluramine as an adjunct to a reduced-fat, ad libitum diet: effects on body composition, nutrient intake and cardiovascular risk factors.
    Swinburn BA; Carmichael HE; Wilson MR
    Int J Obes Relat Metab Disord; 1996 Nov; 20(11):1033-40. PubMed ID: 8923161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dexfenfluramine treatment on body weight and postprandial thermogenesis in obese subjects. A double-blind placebo-controlled study.
    Lafreniere F; Lambert J; Rasio E; Serri O
    Int J Obes Relat Metab Disord; 1993 Jan; 17(1):25-30. PubMed ID: 8383638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of dexfenfluramine on eating habits in a Dutch ambulatory android overweight population with an overconsumption of snacks.
    Drent ML; Zelissen PM; Koppeschaar HP; Nieuwenhuyzen Kruseman AC; Lutterman JA; van der Veen EA
    Int J Obes Relat Metab Disord; 1995 May; 19(5):299-304. PubMed ID: 7647820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A one-year trial to assess the value of orlistat in the management of obesity.
    James WP; Avenell A; Broom J; Whitehead J
    Int J Obes Relat Metab Disord; 1997 Jun; 21 Suppl 3():S24-30. PubMed ID: 9225173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intakes of most nutrients remain at acceptable levels during a weight management program using the food exchange system.
    Benezra LM; Nieman DC; Nieman CM; Melby C; Cureton K; Schmidt D; Howley ET; Costello C; Hill JO; Mault JR; Alexander H; Stewart DJ; Osterberg K
    J Am Diet Assoc; 2001 May; 101(5):554-61. PubMed ID: 11374349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An ad libitum, very low-fat diet results in weight loss and changes in nutrient intakes in postmenopausal women.
    Mueller-Cunningham WM; Quintana R; Kasim-Karakas SE
    J Am Diet Assoc; 2003 Dec; 103(12):1600-6. PubMed ID: 14647085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of consumption of a novel fat emulsion in relation to body-weight management.
    Diepvens K; Soenen S; Steijns J; Arnold M; Westerterp-Plantenga M
    Int J Obes (Lond); 2007 Jun; 31(6):942-9. PubMed ID: 17299383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of recombinant human leptin treatment as an adjunct of moderate energy restriction on body weight, resting energy expenditure and energy intake in obese humans.
    Fogteloo AJ; Pijl H; Frölich M; McCamish M; Meinders AE
    Diabetes Nutr Metab; 2003 Apr; 16(2):109-14. PubMed ID: 12846450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a serotonin re-uptake inhibitor, fluoxetine, in the treatment of obesity.
    Levine LR; Rosenblatt S; Bosomworth J
    Int J Obes; 1987; 11 Suppl 3():185-90. PubMed ID: 3501994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutrient adequacy during weight loss interventions: a randomized study in women comparing the dietary intake in a meal replacement group with a traditional food group.
    Ashley JM; Herzog H; Clodfelter S; Bovee V; Schrage J; Pritsos C
    Nutr J; 2007 Jun; 6():12. PubMed ID: 17592648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.